"Strongyloidiasis" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Infection with nematodes of the genus STRONGYLOIDES. The presence of larvae may produce pneumonitis and the presence of adult worms in the intestine could lead to moderate to severe diarrhea.
| Descriptor ID |
D013322
|
| MeSH Number(s) |
C03.335.508.700.700.799
|
| Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Strongyloidiasis".
Below are MeSH descriptors whose meaning is more specific than "Strongyloidiasis".
This graph shows the total number of publications written about "Strongyloidiasis" by people in this website by year, and whether "Strongyloidiasis" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2016 | 4 | 0 | 4 |
| 2017 | 8 | 2 | 10 |
| 2018 | 8 | 1 | 9 |
| 2019 | 6 | 0 | 6 |
| 2020 | 3 | 0 | 3 |
To return to the timeline, click here.
Below are the most recent publications written about "Strongyloidiasis" by people in Profiles.
-
Strongyloides in bronchoalveolar lavage fluid: practical implications in the COVID-19 era. J Travel Med. 2022 01 17; 29(1).
-
Reactive Arthritis Update: Spotlight on New and Rare Infectious Agents Implicated as Pathogens. Curr Rheumatol Rep. 2021 07 01; 23(7):53.
-
Eosinophilic appendicitis due to Strongyloides stercoralis: a challenging differential diagnosis for clinicians. BMJ Case Rep. 2021 Jun 01; 14(6).
-
Dexamethasone and COVID-19: Strategies in Low- and Middle-Income Countries to Tackle Steroid-Related Strongyloides Hyperinfection. Am J Trop Med Hyg. 2021 Mar 15; 104(5):1611-1612.
-
Risk of Strongyloides Hyperinfection Syndrome when prescribing dexamethasone in severe COVID-19. Travel Med Infect Dis. 2021 Mar-Apr; 40:101981.
-
Antimicrobial Management of Disseminated Strongyloidiasis in a COVID-19 Patient. Am J Trop Med Hyg. 2020 11; 103(5):2150.
-
Concurrent Antibiotic Therapy in Disseminated Strongyloidiasis. Am J Trop Med Hyg. 2020 11; 103(5):2149.
-
Case Report: Disseminated Strongyloidiasis in a Patient with COVID-19. Am J Trop Med Hyg. 2020 10; 103(4):1590-1592.
-
Strongyloides infection manifested during immunosuppressive therapy for SARS-CoV-2 pneumonia. Infection. 2021 Jun; 49(3):539-542.
-
COVID-19 and Dexamethasone: A Potential Strategy to Avoid Steroid-Related Strongyloides Hyperinfection. JAMA. 2020 Aug 18; 324(7):623-624.